Cargando…
Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy()
This article traces back thirty years of biotechnology research sponsored by the European Union (EU). It outlines the crucial role played by De Nettancourt, Goffeau and Van Hoeck to promote and prepare the first European programme on biotechnology (1982–1986) run by the European Commission. Followin...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128756/ https://www.ncbi.nlm.nih.gov/pubmed/23195849 http://dx.doi.org/10.1016/j.nbt.2012.11.014 |
_version_ | 1783516635158544384 |
---|---|
author | Aguilar, Alfredo Magnien, Etienne Thomas, Daniel |
author_facet | Aguilar, Alfredo Magnien, Etienne Thomas, Daniel |
author_sort | Aguilar, Alfredo |
collection | PubMed |
description | This article traces back thirty years of biotechnology research sponsored by the European Union (EU). It outlines the crucial role played by De Nettancourt, Goffeau and Van Hoeck to promote and prepare the first European programme on biotechnology (1982–1986) run by the European Commission. Following this first biotechnology programme, others followed until the current one, part of the seventh Framework Programme for Research, Technological Development and Demonstration (2007–2013) (FP7). Particular attention is given to the statutory role of the European institutions in the design and orientation of the successive biotechnology programmes, compared to the more informal – yet visionary – role of key individuals upstream to any legislative decision. Examples of success stories and of the role of the biotechnology programmes in addressing societal issues and industrial competitiveness are also presented. Finally, an outline of Horizon 2020, the successor of FP7, is described, together with the role of biotechnology in building the bioeconomy. |
format | Online Article Text |
id | pubmed-7128756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71287562020-04-08 Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy() Aguilar, Alfredo Magnien, Etienne Thomas, Daniel N Biotechnol Feature This article traces back thirty years of biotechnology research sponsored by the European Union (EU). It outlines the crucial role played by De Nettancourt, Goffeau and Van Hoeck to promote and prepare the first European programme on biotechnology (1982–1986) run by the European Commission. Following this first biotechnology programme, others followed until the current one, part of the seventh Framework Programme for Research, Technological Development and Demonstration (2007–2013) (FP7). Particular attention is given to the statutory role of the European institutions in the design and orientation of the successive biotechnology programmes, compared to the more informal – yet visionary – role of key individuals upstream to any legislative decision. Examples of success stories and of the role of the biotechnology programmes in addressing societal issues and industrial competitiveness are also presented. Finally, an outline of Horizon 2020, the successor of FP7, is described, together with the role of biotechnology in building the bioeconomy. Elsevier B.V. 2013-06-25 2012-11-26 /pmc/articles/PMC7128756/ /pubmed/23195849 http://dx.doi.org/10.1016/j.nbt.2012.11.014 Text en Copyright © 2012 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Feature Aguilar, Alfredo Magnien, Etienne Thomas, Daniel Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy() |
title | Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy() |
title_full | Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy() |
title_fullStr | Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy() |
title_full_unstemmed | Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy() |
title_short | Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy() |
title_sort | thirty years of european biotechnology programmes: from biomolecular engineering to the bioeconomy() |
topic | Feature |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128756/ https://www.ncbi.nlm.nih.gov/pubmed/23195849 http://dx.doi.org/10.1016/j.nbt.2012.11.014 |
work_keys_str_mv | AT aguilaralfredo thirtyyearsofeuropeanbiotechnologyprogrammesfrombiomolecularengineeringtothebioeconomy AT magnienetienne thirtyyearsofeuropeanbiotechnologyprogrammesfrombiomolecularengineeringtothebioeconomy AT thomasdaniel thirtyyearsofeuropeanbiotechnologyprogrammesfrombiomolecularengineeringtothebioeconomy |